Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hiroko Science Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. CHHAY, BONIRATH is the examiner, and the matter is assigned to 1 art unit.
The proceeding is fully concentrated in one examination assignment. A matter-specific response strategy is appropriate, with attention directed to the record and the examiner's stated concerns.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHHAY, BONIRATH | 1 | 62.5% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18851050 | PHARMACEUTICAL COMPOSITION CONTAINING miR-140 AND METHOD FOR PRODUCING SAME | CHHAY, BONIRATH | 1645 | §103 | Final Rejection | — | Pending | Sep 25, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHiroko Science Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Bonirath Chhay has the most, with 1 of Hiroko Science Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.